186 related articles for article (PubMed ID: 38001070)
1. Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities.
Krais JJ; Glass DJ; Chudoba I; Wang Y; Feng W; Simpson D; Patel P; Liu Z; Neumann-Domer R; Betsch RG; Bernhardy AJ; Bradbury AM; Conger J; Yueh WT; Nacson J; Pomerantz RT; Gupta GP; Testa JR; Johnson N
Nat Commun; 2023 Nov; 14(1):7714. PubMed ID: 38001070
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.
Sullivan-Reed K; Toma MM; Drzewiecka M; Nieborowska-Skorska M; Nejati R; Karami A; Wasik MA; Sliwinski T; Skorski T
Mol Cancer Res; 2023 Oct; 21(10):1017-1022. PubMed ID: 37358557
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors.
Fried W; Tyagi M; Minakhin L; Chandramouly G; Tredinnick T; Ramanjulu M; Auerbacher W; Calbert M; Rusanov T; Hoang T; Borisonnik N; Betsch R; Krais JJ; Wang Y; Vekariya UM; Gordon J; Morton G; Kent T; Skorski T; Johnson N; Childers W; Chen XS; Pomerantz RT
Nat Commun; 2024 Apr; 15(1):2862. PubMed ID: 38580648
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting.
Ronson GE; Starowicz K; Anthony EJ; Piberger AL; Clarke LC; Garvin AJ; Beggs AD; Whalley CM; Edmonds MJ; Beesley JFJ; Morris JR
Nat Commun; 2023 Nov; 14(1):7834. PubMed ID: 38030626
[TBL] [Abstract][Full Text] [Related]
5. Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
Zatreanu D; Robinson HMR; Alkhatib O; Boursier M; Finch H; Geo L; Grande D; Grinkevich V; Heald RA; Langdon S; Majithiya J; McWhirter C; Martin NMB; Moore S; Neves J; Rajendra E; Ranzani M; Schaedler T; Stockley M; Wiggins K; Brough R; Sridhar S; Gulati A; Shao N; Badder LM; Novo D; Knight EG; Marlow R; Haider S; Callen E; Hewitt G; Schimmel J; Prevo R; Alli C; Ferdinand A; Bell C; Blencowe P; Bot C; Calder M; Charles M; Curry J; Ekwuru T; Ewings K; Krajewski W; MacDonald E; McCarron H; Pang L; Pedder C; Rigoreau L; Swarbrick M; Wheatley E; Willis S; Wong AC; Nussenzweig A; Tijsterman M; Tutt A; Boulton SJ; Higgins GS; Pettitt SJ; Smith GCM; Lord CJ
Nat Commun; 2021 Jun; 12(1):3636. PubMed ID: 34140467
[TBL] [Abstract][Full Text] [Related]
6. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
[TBL] [Abstract][Full Text] [Related]
7. Excess Polθ functions in response to replicative stress in homologous recombination-proficient cancer cells.
Goullet de Rugy T; Bashkurov M; Datti A; Betous R; Guitton-Sert L; Cazaux C; Durocher D; Hoffmann JS
Biol Open; 2016 Oct; 5(10):1485-1492. PubMed ID: 27612511
[TBL] [Abstract][Full Text] [Related]
8. Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis.
Gelot C; Kovacs MT; Miron S; Mylne E; Haan A; Boeffard-Dosierre L; Ghouil R; Popova T; Dingli F; Loew D; Guirouilh-Barbat J; Del Nery E; Zinn-Justin S; Ceccaldi R
Nature; 2023 Sep; 621(7978):415-422. PubMed ID: 37674080
[TBL] [Abstract][Full Text] [Related]
9. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
10. POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells.
Schrempf A; Bernardo S; Arasa Verge EA; Ramirez Otero MA; Wilson J; Kirchhofer D; Timelthaler G; Ambros AM; Kaya A; Wieder M; Ecker GF; Winter GE; Costanzo V; Loizou JI
Cell Rep; 2022 Nov; 41(9):111716. PubMed ID: 36400033
[TBL] [Abstract][Full Text] [Related]
11. POLθ prevents MRE11-NBS1-CtIP-dependent fork breakage in the absence of BRCA2/RAD51 by filling lagging-strand gaps.
Mann A; Ramirez-Otero MA; De Antoni A; Hanthi YW; Sannino V; Baldi G; Falbo L; Schrempf A; Bernardo S; Loizou J; Costanzo V
Mol Cell; 2022 Nov; 82(22):4218-4231.e8. PubMed ID: 36400008
[TBL] [Abstract][Full Text] [Related]
12. Targeting Polymerase Theta (POLθ) for Cancer Therapy.
Patterson-Fortin J; D'Andrea AD
Cancer Treat Res; 2023; 186():285-298. PubMed ID: 37978141
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
Hamid AB; Frank LE; Bouley RA; Petreaca RC
PLoS One; 2022; 17(9):e0273736. PubMed ID: 36107942
[TBL] [Abstract][Full Text] [Related]
14. Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides
Voutsadakis IA; Stravodimou A
Anticancer Res; 2023 Mar; 43(3):967-981. PubMed ID: 36854505
[TBL] [Abstract][Full Text] [Related]
15. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
16. FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair.
Kais Z; Rondinelli B; Holmes A; O'Leary C; Kozono D; D'Andrea AD; Ceccaldi R
Cell Rep; 2016 Jun; 15(11):2488-99. PubMed ID: 27264184
[TBL] [Abstract][Full Text] [Related]
17. Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.
Mengwasser KE; Adeyemi RO; Leng Y; Choi MY; Clairmont C; D'Andrea AD; Elledge SJ
Mol Cell; 2019 Mar; 73(5):885-899.e6. PubMed ID: 30686591
[TBL] [Abstract][Full Text] [Related]
18. DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.
Vekariya U; Toma M; Nieborowska-Skorska M; Le BV; Caron MC; Kukuyan AM; Sullivan-Reed K; Podszywalow-Bartnicka P; Chitrala KN; Atkins J; Drzewiecka M; Feng W; Chan J; Chatla S; Golovine K; Jelinek J; Sliwinski T; Ghosh J; Matlawska-Wasowska K; Chandramouly G; Nejati R; Wasik M; Sykes SM; Piwocka K; Hadzijusufovic E; Valent P; Pomerantz RT; Morton G; Childers W; Zhao H; Paietta EM; Levine RL; Tallman MS; Fernandez HF; Litzow MR; Gupta GP; Masson JY; Skorski T
Blood; 2023 May; 141(19):2372-2389. PubMed ID: 36580665
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.
Zong D; Adam S; Wang Y; Sasanuma H; Callén E; Murga M; Day A; Kruhlak MJ; Wong N; Munro M; Ray Chaudhuri A; Karim B; Xia B; Takeda S; Johnson N; Durocher D; Nussenzweig A
Mol Cell; 2019 Mar; 73(6):1267-1281.e7. PubMed ID: 30704900
[TBL] [Abstract][Full Text] [Related]
20. Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair.
Zahn KE; Jensen RB
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
